primary question Can DBT reduce self-injurious behavior and drug abuse among people with borderline personality disorder? patient benefit Six randomized controlled trials compared DBT to other psychiatric treatment. A large percentage of women were included in these trials. The duration of treatment was usually 1 year, and the outcomes varied by study, partly because different subgroups were studied. The results show that DBT leads to a reduction in self-injurious behavior and fewer dropouts from treatment. The effects were found to remain in followup for up to 2 years. Treatment also appeared to reduce the need for hospitalization and reduce drug use among substance abusers. There is no evidence to show that treatment outcomes would be influenced in patients who are also diagnosed with substance abuse. Likewise, there are no confirmed results concerning the impact of different treatment components on the outcome. economic aspects A Swedish study investigated the cost of dialectical behavioral therapy. The total annual cost, per patient, for care decreased from 320 000 Swedish kronor (SEK) in the year before treatment commenced to 210 000 SEK when treatment was given. Health economic studies are needed to investigate the cost effectiveness of the method.
SBU's appraisal of the evidence
There is limited scientific evidence showing that DBT reduces self-injurious behavior and that the effect remains at 2-year followup (Evidence grade 3)*. Treatment also appears to reduce the need for hospitalization and reduce drug use among people with addictions. Hence, DBT appears to be a promising form of treatment for patients with borderline personality disorder. However, it needs to be tested under Swedish conditions, and it is essential to conduct studies addressing the cost effectiveness of the method. 
